Anticancer effects of garlic and garlic-derived compounds for breast cancer control

Area of Science:

• Oncology
• Nutritional Science
• Biochemistry

Background:

• Breast cancer remains a significant global health concern.
• Dietary factors, including garlic consumption, are investigated for their role in cancer prevention.
• Garlic contains bioactive compounds with potential chemopreventive properties.

Purpose of the Study:

• To evaluate the efficacy of garlic and its derivatives in preventing and treating breast cancer.
• To elucidate the mechanisms by which garlic compounds exert anti-cancer effects.
• To compare the effectiveness of different garlic-derived compounds, including organosulfur and organoselenium forms.

Main Methods:

• In vivo studies using animal models of mammary carcinogenesis.
• In vitro studies assessing the effects of garlic compounds on human breast cancer cell lines.
• Analysis of molecular mechanisms, including enzyme activation, DNA adduct formation, reactive oxygen species (ROS) production, cell cycle regulation, and apoptosis induction.

Main Results:

• Garlic and its oil-soluble compounds, like diallyl disulfide (DADS), suppress breast cancer development and growth.
• Mechanisms involve detoxification of carcinogens, reduced DNA damage, controlled ROS, cell cycle arrest, and apoptosis.
• Selenium-enriched garlic demonstrated superior chemopreventive and anti-cancer cell activity compared to natural garlic or organosulfur analogues.
• DADS showed synergistic effects with eicosapentaenoic acid and antagonistic effects with linoleic acid.

Conclusions:

• Garlic and its derived compounds, particularly DADS and selenium-enriched forms, are potent agents against breast cancer.
• These compounds offer a promising natural approach for breast cancer control and may mitigate side effects of conventional therapies.